Showing posts with label press. Show all posts
Showing posts with label press. Show all posts

Sunday, 21 November 2010

In step 4, Endo, poor & adhesions removed = pregnancy! Thomas l. Lyon, MD ...-PR Web (press release)

Endometriosis can have the role of infertility, but it is not the primary issue to prevent women than conceiving, says Dr. Thomas l. Lyons Center women's Care & reproductive function Surgery Atlanta. Patients had told Kate Melioris other doctors, according to his endo and poor would prevent the her pregnancy. Dr. Lyons review.He carried out surgical excision and removal of endo and poor myomectomy. two children and four years later, Kate's family was featured ON CBS-Atlanta's Better Mornings, 10/12/10.




>>
>


In 2004, when Kate Melioris had 37 he spent two or three weeks of each month, the pain, curled in a ball, ran out of bed is requested. His health problems involved in serious phase IV endometriosis and adhesions and two golf ball fibroid tumours of the uterus in his undertakings.


Internet search led to his laparoscopic excision and removal of specialist Dr. endo Tom Lyons, the first question to the patient with the poor is always, "what are your intentions about pregnancy?"He tells you that it is not uncommon to find the endometriosis and the poor, the same patients. Neither disease chronic pelvic pain, which is a known cause.


Although Kate and her husband were only dating back to the time, he's definitely the marriage and children. Other doctors had told him, he would never young, but Dr. Lyons ' own track record with the seeming "hopeless cases" talked about otherwise.


Rather than hysterectomy Dr. Lyons run myomectomy delete Kate's poor, surgical excision and removal of (the root of the article number below to view the Elimination of all forms of endometriosis) and adhesions, all make the small bodies, who received his back to his active life must be taken in rapid deletion.


"When I woke up from surgery 2004 already I felt better than 98%," said Kate, who is a member of the Educational Program at the St. Joseph Development Research Institute.


"If all the idea of how easy it would have had, I never have been kept in pain for so long. To know all of my friends, who are in pain, ' find someone to worry about it! "Of course, I recommend Dr. Lyons, "he said.


"Kate's case, an aggressive surgical excision and removal is required, but we have preserved one of the fallopian tubes, pipes and munasarjasta, uterus," said Dr. Lyons.He is one of the few GYNs in the United States, which shall carry out surgical excision and removal, on the other hand, that the mere use of the surface of the disease, lasering.


Surgical excision and removal of associated with out of the disease, much deeper than the surface of the roots of cutting off lasering. Surface ablation can be deployed quickly, it will grow back, just like weeds, that the mere mowed.According to Dr. Lyons, many patients have had four or five laser treatments, which create an area on top of scarring — and even a greater problem., however, after a thorough surgical excision and removal, they are likely to be at least 10 years free of pain.


Dr. Lyons explained that the procedure takes place via a small bodies using minimally invasive surgery in such a way as to be less visible scarring of the patient's pain, abdomen. can be reduced immediately."Often we can find them in the mall with a friendly alarm call the next," he laughed. www.thomasllyons.com


Two children Later …Kate opted for LSH


Kate married daughter and son and gave several years later seemed familiar to the pelvic pain and endometriosis. Disease occurs when the endometrial tissue, tissue that lines the uterus and during menstruation: specimens that form part of the outside of the uterus to grow.


"I think it may have a role to play in infertility endometriosis, but it is not the primary role," said Dr. Lyons, book What Do When doctor says it's endometriosis or poor: Everything You Need to Know the stop Pain and Heal your fertility (Fair winds Press).


July 2010, Kate came back to Dr. Lyons Laparoscopic Supracervical Hysterectomy-, in 1989, he developed a procedure which keeps the cervix to support women's place as aloittamallaan anatomy. He has trained surgeons around the world, hundreds of his LSH-technology.


Kate had his surgery performed Thursday and back to work after was Monday. within two weeks after he took his children to stay in a Florida.


"I knew Dr. Lyons was good; I felt very comfortable for him, because he is so low-keyed. most surgeons operate like rock stars – all ego — and he must hold that the transfer of data at all. [1] [2] He was feeling, but what he or she is not over-the-top emotional about. in 2004, of the first procedure after he gave me a video of the surgery and I knew: this is a man who rely on what he does!"said to Kate.


Dr. Lyons, who has been in the women's pelvic endometriosis, substances with pain and infertility problems more than 25 years, says that the correspondence is the key to your doctor.


"Even if you do not care, treatment options, there are many possibilities abound. pain relief with the physical symptoms. individual care assessment exam should own their own quality of life of a doctor in order to improve the way you desire to receive treatment. [1] [2] is responsible for you and your loved. [1] [2] in all of the benefit," he said.


Dr. Lyons Patients seek out around the world developed gynecological procedures, which he has developed, including laparoscopic supracervical hysterectomy and laparoscopic Burch procedure for urinary stress incontinence. She also trains surgeons around the world in these procedures.


View the original article here

Saturday, 20 November 2010

Gynecological onkologian Associates Dr. raminin Mirhashemi, MD handles ...-PR Newswire (press release)

Click to view news release full screen

TORRANCE, Calif., Sept 28/PRNewswire/--rotissa poor affects more than 30% of American women. However, many of the exhibition, the symptoms and do not therefore need the fibroid treatment. Treatment is only required for the poor, rotissa if the poor are large enough to cause the pressure applied to the other bodies (such as the Bladder), is growing rapidly, the cause of abnormal bleeding or cause problems with fertility. The symptoms are usually poor Rotissa heavy or abnormal bleeding and discomfort, but most women's biggest concern is the difficulty in conceiving a baby.




>
>


Dr. raminin Mirhashemi, Gynecological onkologian Associates "minimally invasive fibroid surgery improved rotissa poor, fewer problems and a faster recovery," says. "With the technology and automatic hysterectomy will improve only by way of derogation from the procedure."Da Vinci robotic surgery on the surgeon makes a small bodies in accordance with the procedure laid down in insert tools and monitor the application of a small camera, which is the subject of a patient.


It is important to keep the poor from the fertility and the design and implantation of the embryo of the wall and to facilitate the full rotissa validity, healthy pregnancy. Hysterectomy is a popular rotissa fibroid treatment, but it also removes the ability of the child, a woman maaseutuyhteisöjä. Traditional open surgery can also affect fertility scar tissue, which is based on the uterus Spiegelin from it.


There is also other less invasive treatments, which are maksafibroosin fewer characters for the patient, but still cannot keep fertility.Dr. Mirhashemi, which has the most experience in the Western United States gynecologic conditions for increased use of automatic surgery "simply put, uterus cannot be sewn back together sufficiently well to ensure healthy full-term pregnancy," said He and his staff. [1] [2] Gynecological Associates to provide comprehensive care onkologian, skills and individual attention to each patient seeking optimal gynecological care.


Thanks to the automatic use of surgeons surgery smaller tools for greater accuracy, and various of its own motion.Dr. Mirhashemi as surgeons is located close to the patient through the console inside of the monitor and control the identification of controls, and foot pedals, the robot is the camera gives a surgeon. [1] [2] in the 3D view with up to 15 X magnification. "The robot helps me See a very small blood vessels and nerves, which may spare parts, which may give rise to very little damage to surrounding tissues, "said Mirhashemi.


Dr. Mirhashemi offers these useful tips rotissa poor:

Always call your doctor If heavy bleeding, pain or forest issues. Fibroids are typically benign consists of fibrous tissues and can be found in the proper muscle. in General, Fibroids, udder rotissa wall of the uterus or outside of the poor are generally more prevalent. [3] [4] women their richest. they grow more than one tumor, or Uterine size varies according to the clusters of the poor. [1] [2] are the most common type of pelvic tumours seen gynecologists.

"When the automatic surgery popularity grows and gains acceptance, women may be the most dangerous with safer, high-performance computing (HPC) with the removal of fibroid ensures greater opportunity to preserve fertility," said Dr. Mirhashemi.


www.gynla.com


SOURCE www.gynla.com

Back to the beginning of the

RELATED LINKS
http://www.gynla.com


View the original article here

Wednesday, 17 November 2010

Stop the Medical receives Canadian License Fibroid treatment Device-PR Newswire (press release)

LIVERMORE, Calif., October 18/PRNewswire/--after Medical, Inc. announced today that it has been approved in Canada for Tulip ™ sentyyppisestä flask Thermal ablation (RFVTA)-the placing on the market of the probe. "We've just received Health Canada license for puts us closer to our goal, is an important step in making available to the women in North America, which suffer from poor millions of our rotissa rotissa sparing procedure," said Russ, President and CEO of DeLonzor, stop the Medical.   "Approvals in Canada and you have now received the European Union and for general use, as well as our recent rotissa poor to the global market for use in dentistry (is not separately reported poor) Administration in the United States, our products, THE FDA is us very well placed in the brokering activities to bring our solutions for most of the major global markets in the near future," said DeLonzor.




>
>


Information about the audit of the Medical, Inc.  


Stop the Medical, Inc. is a medical device which forms part of a planning and close to San Francisco, CA the manufacture of products from developing countries, the company for the next generation of RFVTA ablate tissues with the system.Audit of the system for general use, THE FDA has been cleared and is currently in the United States and Latin America, the relief shall continue to be problems caused by poor rotissa. Stop prepares commercialised stop Fibroid System on the market, if it has already been approved for general surgical and fibroid indications outside the United States, the global business opportunity to stop the. Fibroid System more than $ 2billion is estimated to be on an annual basis.


For information about how to stop the fibroid, clinical research and a list of strings, numbers, in the United States at www.clinicaltrials.gov NCT00874029 research.


SOURCE after Medical, Inc.

Back to the beginning of the

RELATED LINKS
http://www.haltmedical.com


View the original article here

Friday, 22 October 2010

InSightec: start the ExAblate - Fibroid etc Story

TIRAT CARMEL, Israel, 29 September 2010/PRNewswire/--InSightec Oy, the world's leading guided Mr Ultrasound technology (MRgFUS) announced today that it will be launching the ExAblate (R) one rotissa poor, women's health and ExAblate (R) or a system operating in the room the meeting future Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2010 future adenomyosis and research settings.

ExAblate (R) family systems employs the Ultrasound non invasively

>
>
heat and destroy the targeted tissue MR control. MRI-the most advanced imaging modality system available today, identify and objectives of the tumours, but in real time temperature monitoring of the treated tissue.


Experience substances of more than 6000 patients over 80 work centers around the world ExAblate family systems offers the proven commercially approved treatments and mature forum and clinical data on a wide variety of research settings.


Innovative ExAblate (R) one to extend the treatment choices for women suffering from rotissa poor and adenomyosis.Recent ExAblate (R) technical progress now large and vascular poor and adenomyosis, expanding patient base. The ability to handle larger volumes are expected to lead to greater fibroid clinical efficacy. ExAblate (R) significantly improve adenomyosis signs, and in many cases, improve the patient's ability to overcome infertility caused by the condition.


Patients on mature rotissa poor or generally return to their normal routine adenomyosis procedure a major improvement over most fibroid treatment techniques within 24 hours. the growing number of Women has become pregnant after exposure ExAblate. studies have shown that can even improve the MRgFUS suffering from infertility caused by rotissa poor fertility. (1)


Places around the world experience has shown that the ExAblate MRgFUS increase significantly in the interest of the patient handling and transport of the port facility.Tokyo, Japan's leading site reported that the number of patients treated rotissa poor increased by 550%.(2)


ExAblate treatment has also proven cost-efficient as an alternative to the current treatments, meeting the criteria for acceptable value fibroid treatment.(3)


"MR guided relating to the use of Ultrasound (MRgFUS) has been in the treatment of the poor rotissa approved and viable option in order to increase the number of women for several years. However, the ExAblate (R) with one of the improvements offered by we can provide a more effective, more women to women's health forum is liable for imminent damage which is a fixed result for treatment alternative. "Said the head of the Professor Wladyslaw M Gedroyc, MD, radiology, St. Mary's Hospital, London, United Kingdom. " The maintenance of patients, such as the uterus and the better chance of fertility in addition to the benefits we have seen a significant reduction in the handling of the case. "


ExAblate (R) or the environment is non-invasive image Guided and Controlled Acoustic Operating System will be repeated for each room. convertible cribs with one common shown in the table below.ExAblate (R), or offer commercially accepted and research processing settings across a wide range of clinical data, such as: rotissa poor and adenomyosis, breast cancer, prostate cancer, pain palliation of bone metastases, and other characters.


One of the ExAblate (r) and the ExAblate (R) or compatible with GE Healthcare Signa and product Discovery MRI lines and has just designed ergonomic benefit patients bed, a streamlined interface, and improved usability of doctors.


"Our vision is dedicated to the ExAblate system that offers a truly non-invasive treatment, extended selection and is addressed to the safety profile. ExAblate (R) 2000 in 2004, after the introduction of market researchers, clinical and must continue to further improve and enhance innovation and accumulating compensated clinical information and knowledge," said Dr. Kobi Vortman, President and CEO, InSightec. "We control system based on the Mr Ultrasound technology only provider to offer such good and mature picture Wizard and ambient acoustic surgery".


New ExAblate (R) 1 and ExAblate (R) or patients ' bed featured InSightec booth # 44 CIRSE (2-6, October 2010, Valencia, Spain) is also hosting at. InSightec Satellite symposium, CIRSE October 3rd at the address where the senior researchers will discuss their work in the different areas of ExAblate system.For more information about InSightec is intended to serve CIRSE please visit: http://www.insightec.com


1 Rabinovici J, M, H, K, Gostout BS, Stewart EA Morita Fukunishi MRgFUS Study Group David.The results of Magnetic Resonance-guided Pregnancy active Ultrasound Surgery (MRgFUS) for the conservative treatment of the poor, fertility & rotissa sterility, 2008.


2 Yutaka Nakamura Tetsuya Morita (R) the imposition of ExAblate 2000 Add income OB/GYN Department year InSightec clinical report vol. 2, no 1


3 O'Sullivan AK, Thompson (d), Chu P, Lee DW Stewart EA Weinstein MC. cost-effectiveness of Magnetic Resonance guided ultrasound treatment as well as the poor, health rotissa, 2009 in Technology Assessment J Int. 25: 14-25


About ExAblate (R)


ExAblate (R) one and must be constructed in such a way as to improvements to research, development and dedication to InSightec has unparalleled experience and innovation with the clinical examination doctors around the world.


ExAblate ® 2000 received the CE marking in 2002 and 2004 rotissa poor treatment of the Food and Drug Administration (FDA) approval system received in June 2007, bone metastases pain palliation and adenomyosis June 2010 the European CE marking. ExAblate 2000 has won numerous innovation awards and has been used to treat thousands of patients from around the world.


About InSightec


InSightec Ltd. is a privately held company owned by Elbit Imaging, General Electric, MediTech advisors, LLC and employees., it was created in 1999 to develop breakthrough technological MR controls access to the Ultrasound and convert the next generation of operating systems in the room. Haifa, Israel, close to the Head Office of the company has more than 160 employees and has invested in more than 130 million euro to research, development and clinical trials. United States seat Dallas, Texas. [1] [2] for more information, go to: http://www.insightec.com/


Note to editors:


ExAblate (R) One received the CE marking for management of June 2010, adenomyosis. It has been approved by the FDA.

Media contact: for more information, please contact: Dr. Jane Waggener Edstrom Brearley World Tower House 10 Southampton Street Pancras London WC2E 7HA Email: jbrearley@waggeneredstrom.com phone: + 44 (0) 20 7632-3800

SOURCE InSightec Ltd

Back to the beginning of the

View the original article here

Saturday, 9 October 2010

Fibroid Project to Connect the President

Poor Project (fibroidsproject.com) interviewing Dr. Haywood Brown Gynaecology at Duke University Medical Center-24 September 2010, rotissa poor and obstetrics Department.



>
>


The project in accordance with the social nature of an open call for tenders, questions have been women in various social networks (also known as Twitter, Facebook, etc.).Fibroidsproject.com aims to connect with the experts of the burden of suffering from poor women rotissa.


Renee Brown, founder of the burden of the fibroidsproject.com, suffered from the poor, which culminated in the rotissa myomectomy-surgery to remove the confusion, He remembers. talking to other guests with allergies and most desperately tries to collect the data, and search for it months too scanty-but unlike most other patients, he has decided to do something and organization created in conjunction with the Research technologist/co-founder, Nnamdi g. Osuagwu.


Fibroidsproject.com, which launched officially at the 1st September 2010, the alarm signal, activated by intends not to hope for patients throughout the fibroid rotissa, the place where they glean their accurate and up-to-date information and fulfil the other patients ' condition, Exchange information and to give and receive support.


Information:
Poor-project is the brainchild Renée Brown, career development Transformation at high speed and your personal counselling and career development of Nnamdi g. Osuagwu, Information Technology/Social Media consultant and owner's strategic owner. Poor project is the duo of the first venture into Social entrepreneurship. It shall be responsible for: "make Life with the poor women better."


View the original article here

Friday, 8 October 2010

Fibroid Project deals with the potential, green tea Extract to Treat

New York, NY, 30. September 2010--(pr.com)--poor Project (fibroidsproject.com) interview, Ayman Al-Hendy, Dr. Al-Hendy is Vice Chairman of the Department of obstetrics and Gynaecology and Scientific Director of the Meharry Medical College. He is also active in the OB/GYN Nashville General Hospital and Professor of geography at the University of Vanderbilt University Medical aid Center. Dr. Al-Hendy is an extract from the green tea, which could be used in the treatment of the poor performance of clinical trials rotissa.



>
>


Dr. Al-Hendy and his researchers found that green tea extract may kill human cells, tissue cultures and can destroy leiomyoma fibroid damage in animal models. Dr.Al-Hendy said, if the treatment found to be effective, it will not be able to change the lives of millions of women who are currently the only treatment option for them to exercise their rights hysterectomy in humans.


The symptoms are often poor Rotissa debilitating and excessive a vaginal bleeding, anemia, fatigue and lack of energy. According to Dr. Al-Hendy, women who suffer from poor can lose rotissa work time, medical expenses and is more frequently advanced medical treatment in order to become pregnant – all things that cause emotional and financial difficulties for families.


Poor Project social nature of an open call for tenders, questions are asked, Dr. Al-Hendy is awarded to women in the various social networks (also known as Twitter, Facebook, etc.).Fibroidsproject.com aims to connect with the experts of the burden of suffering from poor women rotissa.


Information:
Poor project is recent poor sufferer, Brown, career development Transformation at high speed and your personal counselling and career development of Nnamdi g. Osuagwu, Information Technology/Social Media consultant and owner's strategic owner Renee brainchild. Poor project is the duo of the first venture into Social entrepreneurship. It shall be responsible for: "make Life with the poor women better."


###


View the original article here

Millions could benefit from a new non invasive treatment

 

Millions could benefit from a new noninvasive spotlighted is the second International MR-guided treatments related to Ultrasound Symposium




>>
>


Newswise — related to Ultrasound Surgery Foundation hosts the 2nd International Symposium on MR-guided related to Ultrasound, Chantilly, Virginia 17-20 October from Leading researchers and clinical. from around the world gathered in a three-day Conference to discuss the latest scientific and revolutionary batteries and promising therapeutic medicine sector.


Joy Polefrone, Ph.d., Scientific Secretary of the Committee for "MR-guided symposium says active ULTRASOUND combines the nuclear magnetic resonance imaging properties of Visual accuracy active ULTRASOUND to noninvasively tumours and other tissues of the discrepancies and dissolve blood clots of blood.". "It also examines the following costs shall be borne by the radiation therapy, and targeted drug delivery, which is a kind of custom in medicine that could dramatically more effective, and reduce the toxic effects of chemotherapy and similar treatments Forum."


Patients ' advances in the field of MR-guided focused ULTRASOUND is expected to lead to a new, highly accurate noninvasive procedures that improve survival and quality of life. "Treatments, which is now included in the hospital remains, the long recovery time and the debilitating side effects could replace the outpatient care treatments for recovery times and few, possible side effects," Polefrone explains.


MR-guided focused ULTRASOUND is used now world-wide work with the poor rotissa. outside of the United States is also approved for the treatment of metastatic bone pain associated with cancer. A variety of other research activities are currently underway. Accumulators spotlighted at symposium in the following areas:


Emerging treatments for patients
? Prostate cancer – a safe, efficient and highly accurate outpatient care treatments that preserves continence patient power and are very common treatments for the disease, a new noninvasive MR-guided focused ULTRASOUND priorities., several symposium presentations and posters in the early stages of human described the results of clinical trials evaluating two different ways. First of all, transurethral device shall be treated as a pilot study of Canadian patients. Second, transrectal, the device is now substances patients is medical work centers in Russia and Singapore.


? Breast cancer – may MR-guided focused ULTRASOUND serve as replacement of lumpectomy that excisionless early breast cancer patients? Japanese researcher, Hidemi Furusawa, m., considers that it has such opportunities.As evidence, which he distributes a new noninvasive technology was used in the treatment of Breast 57 patients ' saving the results of the comparison.


? Is not allowed in common back pain pain-a small, which is not allowed in the joints must be marked clinical problem, cause suffering, particularly the elderly and immobility. Patients that need more than a physical therapy, therapeutic lifestyle-and is not permitted on contributions of capital short-term relief can be processed in a closed installation rhizotomy, noninvasive surgical, which uses heat to destroy nerve endings. United States of America and Japan, as the case may be, shall be subject to inspection by the researchers now active ULTRASOUND MR-guided is not allowed in common ablation efficient approach.During the symposium they report the results of the initial management of patients.


? Essential tremor-MR-guided focused ULTRASOUND field was ignited. last year, the Swiss researchers used a noninvasive technique successfully process the patient the most difficult to — the brain body within the territory of one of the news at the latest.Landmark study is paved with brain disorders, essential tremor, Parkinson's disease, epilepsy, brain tumours, and line a broad spectrum of clinical investigations. in addition to providing for the long-term monitoring data in Switzerland to study, the first symposium offers patients study Preview: follow-on to the assessment of the safety and efficacy of the MR-guided focused ULTRASOUND multicenter clinical examination, refractory medically essential tremor.New study on the predecessor substances Parkinson's disease.


Country research came into the


? Blood-brain barrier disruption-bulk density of blood brain barrier (BBB) has made the brain diseases pharmacological treatment, daunting, if not impossible, task.Which can quickly change thanks to Nathan McDannold, Ph.d. and his colleagues at Brigham and women's Hospital and Harvard Medical School in Boston, Massachusetts.At symposium, they report pre-clinical safety on the provisional findings with localized, short-term disruptions in the BBB was achieved by using bursts, MR-guided focused ULTRASOUND and microbubbles research. they also to another with the same approach was used to deliver chemotherapy associated with metastatic breast cancer tumours as a whole, the results of pre-clinical research BBB.


? Ischemia Clot busting drugs line – such as tPA can no longer be necessary if the investigation is carried out together with the Hoelscher, m., University of California, San Diego proves to be successful. he shall report the first results by using the active ULTRASOUND transcranial MR-guided noninvasively share ("lyse") at present in vivo study blood clots of blood and restore blood flow in the brain.


? Stem cell activation –-be effective, the therapeutic stem cells is home to the target tissue, such as months, however, the existing flame. pathologies prevent most of the target tissue release enough chemo-Attractants draw stem cells in order to limit the number of successful health care institutes scientists explain how they have used to create a local version of the active ULTRASOUND chemo-Attractants, adding any bone marrow stromal called multi-homing instincts.


Polefrone says, the symposium also feature leading edge Benign Prostatic Hyperplasia (BPH), pancreatic and liver, bone tumours, rotissa poor, targeted drug delivery and the various aspects of mutual recognition-guided active ULTRASOUND technology.


Program information, reporter queries
You can find the symposium program, click here to view the October 19 poster session include handouts, click for Suppliers who are interested can take part in the symposium, please contact the Foundation's Director of Communications, Ellen c. McKenna.


Active Ultrasound Surgery Foundation information
In 2006, and based in Charlottesville, Virginia, related to Ultrasound Surgery Foundation is dedicated to the treatments of patients in one of today's revolutionary and promising medical technologies research and by accelerating the Magnetic Resonance-guided noninvasive: related to Ultrasound (a) the work of the Foundation. do not think that is is motivated by a could become a bit invasive surgery, radiation therapy, ultimate, serve a viable option and provide accurate drug delivery-uses that may alleviate suffering, save lives and millions of patients ' recovery time quicken worldwide new platform.


By promoting communication, cooperation and coordination of the Foundation has become a central nexus, clinical researchers, manufacturers, and other stakeholders to philanthropists in the arena. Foundation at bringing basic knowledge through to clinical research grants and training doctors and researchers, symposia and workshops, hosting online informational resources preservation and Focused Ultrasound Centers of excellence in their work of the Foundation and the establishment of a. further information can be found from http://fusfoundation.org/




View the original article here